These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2240057)

  • 1. The spectrum of ciclosporin nephrotoxicity.
    Puschett JB; Greenberg A; Holley J; McCauley J
    Am J Nephrol; 1990; 10(4):296-309. PubMed ID: 2240057
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic irreversible nephrotoxicity from cyclosporin A.
    Rao KV; Crosson JT; Kjellstrand CM
    Nephron; 1985; 41(1):75-7. PubMed ID: 3897887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does calcium antagonist improve established early ciclosporin nephrotoxicity after renal transplantation?
    Morales JM; Andres A; Montoyo C; Ortuño B; Rodicio JL
    Nephron; 1991; 57(2):227-9. PubMed ID: 2020352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic nephrotoxicity due to ciprofloxacin and cyclosporine.
    Avent CK; Krinsky D; Kirklin JK; Bourge RC; Figg WD
    Am J Med; 1988 Sep; 85(3):452-3. PubMed ID: 3046358
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine nephrotoxicity.
    Barton CH; Vaziri ND
    Int J Artif Organs; 1985 Nov; 8(6):291-6. PubMed ID: 4077286
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrotoxicity of a nonionic (iopamidol) versus an ionic (diatrizoate) contrast agent in the patient after cardiac transplant with moderate cyclosporine-induced renal insufficiency.
    Denys BG; Reddy PS; Uretsky BF
    Am J Cardiol; 1989 Aug; 64(5):405-6. PubMed ID: 2667306
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine nephrotoxicity and the role of cyclosporine in living-related donor transplantation.
    Paller MS
    Am J Kidney Dis; 1990 Nov; 16(5):414-6. PubMed ID: 2239930
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful combined heart and kidney transplantation for ischemic heart disease in polycystic kidney disease.
    Guillemain R; Farge D; Dreyfus G; Amrein C; Vulser C; Couetil JP; Carpentier A
    Transplant Proc; 1990 Aug; 22(4):1466-7. PubMed ID: 2389367
    [No Abstract]   [Full Text] [Related]  

  • 9. [The clinical results of cadaveric renal transplantation using ciclosporin].
    Arima M; Miyamoto I; Ogino T; Hosokawa S; Matsui T; Yabumoto H; Tsujimoto Y; Ihara H; Terakawa T; Shima H
    Nihon Hinyokika Gakkai Zasshi; 1988 Jul; 79(7):1187-92. PubMed ID: 3073249
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrotoxicity of immunosuppressive drugs.
    Bennett WM; Burdmann EA; Andoh TF; Houghton DC; Lindsley J; Elzinga LW
    Nephrol Dial Transplant; 1994; 9 Suppl 4():141-5. PubMed ID: 7528363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A and hypertension.
    Schachter M
    J Hypertens; 1988 Jul; 6(7):511-6. PubMed ID: 3049794
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression after heart transplantation. Clinical results in three ciclosporin-based immunosuppressive protocols.
    Schüler S; Hetzer R
    Bibl Cardiol; 1988; (43):10-8. PubMed ID: 3067707
    [No Abstract]   [Full Text] [Related]  

  • 13. Nephrotoxicity of cyclosporine in liver transplantation.
    Iwatsuki S; Esquivel CO; Klintmalm GB; Gordon RD; Shaw BW; Starzl TE
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):191-5. PubMed ID: 3895661
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
    Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine nephropathy after heart and heart-lung transplantation.
    Goldstein J; Thoua Y; Wellens F; Leclerc JL; Vanherweghem JL; Vereerstraeten P; Primo G; Toussaint C
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():973-81. PubMed ID: 3921960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical problems in cyclosporine dosing with reference to clinical pharmacology: case histories and discussion.
    Kahan BD
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):16-40. PubMed ID: 2662534
    [No Abstract]   [Full Text] [Related]  

  • 17. Current immunosuppressive strategies in kidney transplantation.
    Land W; Schleibner S; Schneeberger H; Schilling M
    Contrib Nephrol; 1990; 86():146-62; discussion 162-4. PubMed ID: 2078949
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine-associated nephrotoxicity is not intractable.
    Loertscher R
    Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrotoxicity of parenterally administered cyclosporine after orthotopic liver transplantation.
    Powell-Jackson PR; Young B; Calne RY; Williams R
    Transplantation; 1983 Nov; 36(5):505-8. PubMed ID: 6356514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.